[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $mgnx MGNX sees mixed signals as Barclays initiates coverage with an Overweight rating, but social activity and sentiment are down. ### About $mgnx MacroGenics, Inc. (MGNX) is a biotechnology company. ### Insights [#](/topic/$mgnx/insights) - $mgnx engagements is up XXXXXX% from the previous week. - $mgnx posts created is up XXX% from the previous week. ### Engagements: XXXXX [#](/topic/$mgnx/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$mgnx/time-series/interactions.tsv) **Current Value**: XXXXX **Daily Average**: XXXXX **1 Week**: XXXXX +320% **1 Month**: XXXXX -XX% **1-Year High**: XXXXXXX on 2025-06-04 **1-Year Low**: XX on 2025-05-03 | Social Network | X | | -------------- | - | | Engagements | XXXXX | ### Mentions: XX [#](/topic/$mgnx/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$mgnx/time-series/posts_active.tsv) **Current Value**: XX **Daily Average**: XX **1 Month**: XX -XX% **1-Year High**: XXX on 2025-06-27 **1-Year Low**: X on 2025-09-26 | Social Network | X | | -------------- | - | | Mentions | XX | ### Creators: XX [#](/topic/$mgnx/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$mgnx/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning $mgnx in the last XX hours which is up XX% from X in the previous XX hours **Daily Average**: XX **1 Month**: X -XX% **1-Year High**: XXX on 2025-06-27 **1-Year Low**: X on 2025-09-26 The most influential creators that mention $mgnx in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@bioinvestor24](/creator/twitter/bioinvestor24) | X | XXXXX | X | XXXXX | | [@BAMBossie81](/creator/twitter/BAMBossie81) | X | XXX | X | XXX | | [@Biobeats99](/creator/twitter/Biobeats99) | X | XXX | X | XX | [View More](/list/creators/$mgnx/100) ### Sentiment: XX% [#](/topic/$mgnx/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$mgnx/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Month**: XX% +33% **1-Year High**: XXX% on 2025-05-13 **1-Year Low**: XX% on 2025-09-11 **Most Supportive Themes** - **Positive Analyst Coverage:** (10%) Barclays initiates coverage with an Overweight rating, potentially indicating a positive outlook. **Most Critical Themes** - **Bearish Sentiment:** (20%) Despite the positive coverage, long-term bearish sentiment persists. - **Declining Social Activity:** (70%) Overall social activity is down, with engagements and mentions decreasing. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXXXX | XX% | XXX | XX% | X | X% | | | | | | | | | | Total | XXXXX | XX% | XXX | XX% | X | X% | **Top assets mentioned** In the posts about $mgnx in the last XX hours [Merus N.V. Common Shares (MRUS)](/topic/$mrus) [Merck & Co., Inc. (MRK)](/topic/$mrk) [ImmunityBio, Inc. Common Stock (IBRX)](/topic/$ibrx) [Dawn Protocol (DAWN)](/topic/dawn-protocol) [Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences) [Sarepta Therapeutics, Inc. (SRPT)](/topic/sarepta-therapeutics-inc) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova) [Sanofi (SNY)](/topic/sanofi) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) **Top topics mentioned** In the posts about $mgnx in the last XX hours [stocks healthcare](/topic/stocks-healthcare), [$mrus](/topic/$mrus), [investment](/topic/investment), [$mrk](/topic/$mrk), [$ibrx](/topic/$ibrx), [coins nft](/topic/coins-nft), [dawn protocol](/topic/dawn-protocol), [coins defi](/topic/coins-defi), [telegram](/topic/telegram), [$rcus](/topic/$rcus), [gilead sciences](/topic/gilead-sciences), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [$srpt](/topic/$srpt), [$iova](/topic/$iova), [fluffy](/topic/fluffy), [sanofi](/topic/sanofi), [$bmy](/topic/$bmy), [$bmrn](/topic/$bmrn), [bank of america](/topic/bank-of-america), [$ewtx](/topic/$ewtx), [$ltrpa](/topic/$ltrpa), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [stocks consumer defensive](/topic/stocks-consumer-defensive), [stocks financial services](/topic/stocks-financial-services), [exit](/topic/exit), [$sndx](/topic/$sndx), [banger](/topic/banger), [$kura](/topic/$kura), [$mnkd](/topic/$mnkd), [$myok](/topic/$myok), [$mreo](/topic/$mreo), [number of](/topic/number-of), [$sgmo](/topic/$sgmo), [sleeper](/topic/sleeper), [ticker](/topic/ticker), [$sln](/topic/$sln), [coins base ecosystem](/topic/coins-base-ecosystem), [$prqr](/topic/$prqr), [$sny](/topic/$sny), [tariffs](/topic/tariffs), [$abbv](/topic/$abbv), [rivals](/topic/rivals), [$bhvn](/topic/$bhvn), [$incy](/topic/$incy), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$wve](/topic/$wve), [$rnac](/topic/$rnac), [$roiv](/topic/$roiv), [$glpg](/topic/$glpg), [$cytk](/topic/$cytk), [$dawn](/topic/$dawn), [$smmt](/topic/$smmt), [$mgtx](/topic/$mgtx), [$mgx](/topic/$mgx), [molina healthcare inc](/topic/molina-healthcare-inc) ### Top Social Posts [#](/topic/$mgnx/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$MRK phase X in platinum refractory OC today. Big improvement with pembro of X months OS when added to wkly taxol and avastin ( rivals FR ADC data $ABBV ) OS improvement much better than PFS as expected with PD1. Suggests to me adding other proven to work immune mechanisms such as Bispecific PD1-CTLA4 may enhance OS in several settings ( since $BMY used subtherapeutic ipilimumab in most of its trials ) Vs PD1 -VEGF that primarily improves PFS $SMMT with marginal impact on OS $MGNX Pd1 CTLA4 one of the most advanced of this class and in ovarian cancer trial. It could report positive PFS in" [X Link](https://x.com/bioinvestor24/status/1979586142745059736) [@bioinvestor24](/creator/x/bioinvestor24) 2025-10-18T16:31Z 4392 followers, 2406 engagements "$MGNX delivered $SNY #TZIELD = Nat Com Vouch Q4 Data financial injection. Catalysts ahead. See shitty images. But in my mind - Tariffs. If I were a BP would I be building or buying a manufacturing facility Other picks for this Q: $WVE $ALT $ACHV $SGMO $SNDX $IOVA $SLS" [X Link](https://x.com/BAMBossie81/status/1979379430758736266) [@BAMBossie81](/creator/x/BAMBossie81) 2025-10-18T02:50Z XXX followers, XXX engagements "@Soeren_Berlin Nuggets such as $MGNX might walk into XXX million milestone payment according to their last Q earnings filing - based on EU/China apporval MGNX sold to Sanofi Tzield - that just received a National Commissioners Voucher" [X Link](https://x.com/BAMBossie81/status/1979369272942993857) [@BAMBossie81](/creator/x/BAMBossie81) 2025-10-18T02:09Z XXX followers, XXX engagements "Rare quality especially here on X. While I dont consider it fluffy I understand your perspective and we clearly have different levels of insight into the company and whats happening internally which makes your view legitimate from where you stand. Ill check out $MGNX and share my thoughts soon. In return you should take a look at $SLN and $PRQR two underrated darlings of mine with imminent catalysts. $SLN is basically the German version of Sangamo for RNAi weaker scientific evolution just as slow on deal progress but sitting on more cash" [X Link](https://x.com/Soeren_Berlin/status/1979365353525305583) [@Soeren_Berlin](/creator/x/Soeren_Berlin) 2025-10-18T01:54Z 1377 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$mgnx
MGNX sees mixed signals as Barclays initiates coverage with an Overweight rating, but social activity and sentiment are down.
About $mgnx
MacroGenics, Inc. (MGNX) is a biotechnology company.
Insights #
- $mgnx engagements is up XXXXXX% from the previous week.
- $mgnx posts created is up XXX% from the previous week.
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXX +320%
1 Month: XXXXX -XX%
1-Year High: XXXXXXX on 2025-06-04
1-Year Low: XX on 2025-05-03
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XX -XX%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-09-26
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $mgnx in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: XX
1 Month: X -XX%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-09-26
The most influential creators that mention $mgnx in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @bioinvestor24 | X | XXXXX | X | XXXXX |
| @BAMBossie81 | X | XXX | X | XXX |
| @Biobeats99 | X | XXX | X | XX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% +33%
1-Year High: XXX% on 2025-05-13
1-Year Low: XX% on 2025-09-11
Most Supportive Themes
- Positive Analyst Coverage: (10%) Barclays initiates coverage with an Overweight rating, potentially indicating a positive outlook.
Most Critical Themes
- Bearish Sentiment: (20%) Despite the positive coverage, long-term bearish sentiment persists.
- Declining Social Activity: (70%) Overall social activity is down, with engagements and mentions decreasing.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXX | XX% | X | X% |
| Total | XXXXX | XX% | XXX | XX% | X | X% |
Top assets mentioned In the posts about $mgnx in the last XX hours
Merus N.V. Common Shares (MRUS) Merck & Co., Inc. (MRK) ImmunityBio, Inc. Common Stock (IBRX) Dawn Protocol (DAWN) Gilead Sciences, Inc. (GILD) Sarepta Therapeutics, Inc. (SRPT) Sarepta Therapeutics, Inc. (SRPT) Iovance Biotherapeutics, Inc. Common Stock (IOVA) Sanofi (SNY) Bristol-Myers Squibb Co (BMY)
Top topics mentioned In the posts about $mgnx in the last XX hours
stocks healthcare, $mrus, investment, $mrk, $ibrx, coins nft, dawn protocol, coins defi, telegram, $rcus, gilead sciences, sarepta therapeutics inc, $srpt, $iova, fluffy, sanofi, $bmy, $bmrn, bank of america, $ewtx, $ltrpa, stocks consumer cyclical, stocks consumer defensive, stocks financial services, exit, $sndx, banger, $kura, $mnkd, $myok, $mreo, number of, $sgmo, sleeper, ticker, $sln, coins base ecosystem, $prqr, $sny, tariffs, $abbv, rivals, $bhvn, $incy, regeneron pharmaceuticals inc, $wve, $rnac, $roiv, $glpg, $cytk, $dawn, $smmt, $mgtx, $mgx, molina healthcare inc
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$MRK phase X in platinum refractory OC today. Big improvement with pembro of X months OS when added to wkly taxol and avastin ( rivals FR ADC data $ABBV ) OS improvement much better than PFS as expected with PD1. Suggests to me adding other proven to work immune mechanisms such as Bispecific PD1-CTLA4 may enhance OS in several settings ( since $BMY used subtherapeutic ipilimumab in most of its trials ) Vs PD1 -VEGF that primarily improves PFS $SMMT with marginal impact on OS $MGNX Pd1 CTLA4 one of the most advanced of this class and in ovarian cancer trial. It could report positive PFS in"
X Link @bioinvestor24 2025-10-18T16:31Z 4392 followers, 2406 engagements
"$MGNX delivered $SNY #TZIELD = Nat Com Vouch Q4 Data financial injection. Catalysts ahead. See shitty images. But in my mind - Tariffs. If I were a BP would I be building or buying a manufacturing facility Other picks for this Q: $WVE $ALT $ACHV $SGMO $SNDX $IOVA $SLS"
X Link @BAMBossie81 2025-10-18T02:50Z XXX followers, XXX engagements
"@Soeren_Berlin Nuggets such as $MGNX might walk into XXX million milestone payment according to their last Q earnings filing - based on EU/China apporval MGNX sold to Sanofi Tzield - that just received a National Commissioners Voucher"
X Link @BAMBossie81 2025-10-18T02:09Z XXX followers, XXX engagements
"Rare quality especially here on X. While I dont consider it fluffy I understand your perspective and we clearly have different levels of insight into the company and whats happening internally which makes your view legitimate from where you stand. Ill check out $MGNX and share my thoughts soon. In return you should take a look at $SLN and $PRQR two underrated darlings of mine with imminent catalysts. $SLN is basically the German version of Sangamo for RNAi weaker scientific evolution just as slow on deal progress but sitting on more cash"
X Link @Soeren_Berlin 2025-10-18T01:54Z 1377 followers, XXX engagements